MIRA University of Twente
Scientists & UsersFor the scientific audience Industry & EconomyOpportunities for collaboration Public & MediaTop technology for patients Students & EducationLearn about the Master programmes

MIRA News

19 Aug 2014 - TLEMsafe: Improving safety and predictability of complex musculoskeletal surgery As the average lifespan increases, the percentage of aged individuals in populations across developed countries is also growing. This means healthcare systems are presented with a higher incidence of complex musculoskeletal pathologies, such as joint deformation and misalignment or bone and soft-tissue cancer, thus the demand for reconstructive orthopaedic operations is correspondingly rising. 19 Aug 2014 - No support for increasing the volume norm for breast cancer surgery The number of breast cancer surgery which a hospital performs yearly does not play a significant role in the chance of survival. This is the conclusion of research of Sabine Siesling from the University of Twente (MIRA institute) and the Comprehensive Cancer Centre (IKNL) which is published in Breast Cancer Research and Treatment. The study was performed together with the Vereniging Samenwerkende Algemene Ziekenhuizen and medical specialists and does not supports the attention given nowadays to the volume norms for treatment of breast cancer. 18 Aug 2014 - Researchers win international Grand Challenge competition

At the 7th World Congress of Biomechanics, a team of researchers from Aalborg University, Radboudumc, Materialise (Leuven, Belgium) and a research group from Prof. Bart Koopman (from the department of Biomedical Engineering at the Twente University) has been awarded the first prize in the Grand Challenge competition. This competition is a worldwide endeavour in which researchers are challenged to predict loads in the knee joint of a patient who has received a total knee replacement.

11 Aug 2014 - Veni grant for Ruchi Bansal for the development of targeted nano therapeutics against liver fibrosis Ruchi Bansal has successfully received a Veni Grant of EUR 250,000 from The Netherlands Organisation for Scientific Research (NWO). The research project “Targeted Nanotherapeutics: Aiming at the resolution of Liver Fibrosis” will be conducted in the Department of Biomaterials Science and Technology. 21 Jul 2014 - UT-researcher discovers new method for creating bone tissue and cartilage tissue UT-Doctoral Degree Candidate Anne Leferink has discovered a new method for creating bone tissue and cartilage tissue. By sequencing structures, it is possible to create a larger piece of bone tissue or cartilage tissue than was possible with current techniques. The aim is to create as much bone as possible using as few stem cells as possible. The technique has to be injectable, so that complex bone defects such as osteoporosis or arthritis can be treated without surgery. Leferink: “I haven't made any bone yet, but we do expect it to work.” 8 Jul 2014 - New drug-eluting stents more effective Research conducted by University of Twente PhD candidate Kenneth Tandjung has shown that the new generation of drug-eluting stents, which is being used in coronary angioplasty to open narrowed coronary arteries, is safe and more effective than previous generations. He also looked into the use of an additional blood thinner after coronary angioplasty, the influence of diabetes and the results of coronary angioplasty in women. Tandjung is a cardiologist in training at the Thorax Centre of the Medisch Spectrum Twente hospital in Enschede. 7 Jul 2014 - Innovation Grant for Jai Prakash to develop a novel kidney targeting system Jai Prakash has obtained an Innovation grant of EUR 100,000 from Dutch Kidney Foundation for developing a novel kidney targeting system which could be potentially applied for diagnosis and treatment of chronic kidney diseases. The research project will be conducted in close collaboration with Professor Harry van Goor (University Medical Centre Groningen). Currently there are limited ways to diagnose and almost no ways to treat chronic kidney disease. As proposed in this project, specific cell types in fibrotic kidneys will be targeted using ligand-modified nanoparticles. Success of this project can provide new tools for the development of novel diagnostics and therapeutics for chronic kidney disease. 2 Jul 2014 - 600,000 euros in subsidies for research into lung-on-a-chip Chip to accelerate research into lung disease treatments and decrease animal testing